Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

pitcher.com - Jasmine Fleming - You Spoke, We Listened: Top Challenges in Pharma for 2025
You Spoke, We Listened: Top Challenges in Pharma for 2025
Pitcher Home

At the recent NEXT Pharma CX and AI Conference in Vienna, the Pitcher team connected with hundreds of Pharma professionals to discuss the future of the industry. As a sponsor, we engaged with Pharma executives and engagement team leads who shared…

chron.com - BridgeBio Pharma: Q3 Earnings Snapshot
BridgeBio Pharma: Q3 Earnings Snapshot
Chron

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Tuesday reported a loss of $162 million in its third quarter. The Palo Alto, California-based company said it had a loss of 86 cents per share. The…

wsj.com - David Wainer - What the NFL Draft Can Teach Investors About Big Pharma
What the NFL Draft Can Teach Investors About Big Pharma
Wall Street Journal

Few would think professional sports leagues and the drug-development industry have much in common. When it comes to building up a pipeline, though, there is a striking similarity with valuable insights for executives on the prowl for deals. On…

thefederalist.com - Mikale Olson - Big Food And Pharma Shake In Their Boots At A Second Trump Era
Big Food And Pharma Shake In Their Boots At A Second Trump Era
The Federalist: Religion, Politics, and Culture

With Republicans back in charge, Donald Trump's administration is ready, with Robert F. Kennedy Jr. on standby, to take on America's health crisis that's been metastasizing for decades. RFK Jr., likely to be the new health sheriff in town, is ready…

observer.com - Rachel Curry - How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery
How A.I. Is Disrupting Pharma: The High-Stakes Race to Revolutionize Drug Discovery
Observer

For better or worse, A.I. in the pharmaceutical industry has reached a fever pitch—a point of no return. Ever cautious, the Food and Drug Administration (FDA) has stepped in to regulate the burgeoning use of A.I. in drug discovery and…

universalhub.com - Mass. General sues pharma company it says agreed to pay it to test
Mass. General sues pharma company it says agreed to pay it to test
Universal Hub

Massachusetts General Hospital today sued a New York pharmaceutical company it says agreed to pay for the hospital's ALS center to test out a new drug against the currently incurable disease, then tried to worm its way out of its financial…

business-standard.com - SI Reporter - orchid pharma shares: Orchid Pharma up 7% after good Q2 show; PAT up 26%, revenue rises 12%
orchid pharma shares: Orchid Pharma up 7% after good Q2 show; PAT up 26%, revenue rises 12%
Business Standard

Orchid Pharma shares advanced 6.6 per cent on Tuesday and registered an intraday high of Rs 1,534.1 per share on BSE. The stock was in demand after the company reported Q2 results. Around 12:29 PM, Orchid Pharma shares were up 5.71 per cent at Rs…

thehindu.com - Natco Pharma Q2 net surges 83% to ₹677 crore on robust growth in formulation exports
Natco Pharma Q2 net surges 83% to ₹677 crore on robust growth in formulation exports
The Hindu

Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 crore a year earlier, on the back of a robust growth in formulations exports. Total revenue of the company…

business-standard.com - Capital Market - Natco Pharma gains as Q2 PAT jumps 84% YoY to Rs 677 cr
Natco Pharma gains as Q2 PAT jumps 84% YoY to Rs 677 cr
Business Standard

Natco Pharma rose 1.00% to Rs 1,409.70 after the company's consolidated net profit surged 83.55% to Rs 677.30 crore in Q2 FY25 as against Rs 369 crore reported in Q2 FY24. Revenue from operations was at Rs 1,371.1 crore in Q2 FY25, up 32.93% from…

business-standard.com - Capital Market - Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr
Marksans Pharma gains after Q2 PAT rises 16% YoY to Rs 97 cr
Business Standard

Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 over Q2 FY24. The firm stated that growth was…

marketwatch.com - Ciara Linnane - Schrödinger's stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
Schrödinger's stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion
MarketWatch

Schrödinger Inc.'s stock soared 9% early Tuesday, after the company said it has entered a multi-year collaboration agreement with Swiss pharma Novartis AG. Under the terms of the deal, Schrödinger SDGR will receive a $150 million upfront…

thehill.com - Brian Robertson, opinion contributor - Can RFK Jr. put an end to the revolving door between government and industry?
Can RFK Jr. put an end to the revolving door between government and industry?
The Hill

One of the most remarkable aspects of the populist alliance between Robert F. Kennedy Jr. and Donald Trump is that it puts the incoming Republican administration at loggerheads with the very Big Pharma, Big Food and Big Agricultural interests that…

pharmacytimes.com - Christopher Burke - Building Resilience: Opportunities for US Pharma to Strengthen Public Health in Africa Amid Changing Aid Policies
Building Resilience: Opportunities for US Pharma to Strengthen Public Health in Africa Amid Changing Aid Policies
Pharmacy Times

As Donald Trump's re-election raises questions about US foreign aid's future and health care initiatives in Africa, the shifting policy landscape offers an invaluable opportunity for US pharmaceutical companies to expand their impact in emerging…

afaqs.com - afaqs! news bureau - Sumanyu Jain joins KRBL India as Senior Manager-Digital Marketing
Sumanyu Jain joins KRBL India as Senior Manager-Digital Marketing
Afaqs

Sumanyu Jain joins KRBL India as senior manager digital marketing. Previously, he was with Mankind Pharma as assistant manager digital marketing. Jain has a decade of experience in the marketing field, he specialises in planning and executing…

rediff.com - Nandita Malik - Investors become poorer by Rs 5.29 lakh cr as markets slump
Investors become poorer by Rs 5.29 lakh cr as markets slump
Rediff.com

A sharp fall in the equity market made investors poorer by Rs 5.29 lakh crore on Tuesday when the BSE benchmark Sensex tumbled over 800 points. A host of negative triggers -- muted quarterly earnings, continuous foreign fund outflows and weak…

Receive a Daily briefing on Pharma Industry News

Get Started